Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

British Biotech hurt by results of drug trials

Article Abstract:

British Biotech PLC announced that its Marimastat cancer drug experienced another clinical trial. The pancreatic cancer drug's failure led to an approximately 40% decline in the company's value.

Author: Gopalan, Nisha
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
Product development, Abstract, British Biotech PLC, Marimastat (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Alliance's pretax profit falls 9.5%, hurt by competition

Article Abstract:

Alliance and Leicester PLC posted a decline of 9.5% in pretax profits for the 2000 year. The company posted 446.7 million pounds (708.4 million euros) in pretax profits.

Author: Gopalan, Nisha
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
Commercial Banks, Commercial Banking, Sales, profits & dividends, Banking industry, Finance, Alliance & Leicester PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Pharmacia cancer drug is approved by U.S

Article Abstract:

Pharmacia & Upjohn Inc. has been given approval for its breast-cancer drug in the US. The epirubicin drug has already been in use in other countries for several years now. The drug will be marketed under the Ellence name. It had sales of $177 million (170 million euros) in sales in 80 countries in 1998. The drug was approved by the US Food and Drug Administration.

Comment:

Given approval for epirubicin breast-cancer drug in the US

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
United States, Pharmacia and Upjohn Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom, Pharmaceutical industry, Product information, Antineoplastic agents
Similar abstracts:
  • Abstracts: Unilever's pretax profit rises, but concern grows over sales. Unilever expects double-digit gain in net earnings
  • Abstracts: Endesa's operating profit falls, while net rises on Edenor sale. Suez net profit increased 38% in first half
  • Abstracts: Inditex's net profit increases by 31% to 91.7 million euros. Next posts healthy earnings in the first half of 2001
  • Abstracts: A model to optimize project resource allocation by construction of a balanced histogram. Sensitivity analysis of scheduling algorithms
  • Abstracts: Alcatel first-half profit fell 21% on increased research spending. Alcatel expects tough times to linger through next year
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.